辉瑞任命前FDA药物主管为新任首席医疗官兼执行副总裁

医药魔方
25 Feb

2月24日,辉瑞宣布,前FDA药物主管Patrizia Cavazzoni将重新加入辉瑞,担任首席医疗官兼执行副总裁,领导辉瑞的监管、药物警戒、安全、流行病学、医疗信息和证据生成等医疗职能,并向辉瑞研发首席科学官兼总裁Chris Boshoff博士汇报。Cavazzoni博士今年1月辞去了FDA药品审评与研究中心(CDER)主任的职务,入职辉瑞后将接替Aida Habtezion的工作,后者将离开...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10